Bioclinical Study of Scalp Photoaging of a Population Male Over 65 Years Old.

NCT03603587 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2020-03-05

No results posted yet for this study

Summary

The aging of skin, especially that of the scalp, is a combination of intrinsic and extrinsic aging factors secondary to the chronic sun exposure. For men with an alopecia genetic (= bald men), the solar part, in skin aging process, is major.

The helio-dermal scalp is frequently the site of cancers mainly after 65 years. Objectives are to identify specific biomarkers involved in the photo-aging of the alopecic scalp

Conditions

Interventions

PROCEDURE

biopsy

Biopsy 4 to 5 mm from the distal part of the tips of the excision pieces. Three biopsies of 3 mm, made with punch, occipital hair zone (ZT) A completely painless sample, using a swab (soaked with a buffer solution) on the scalp of the ZH and ZT zone.

DIAGNOSTIC_TEST

blood sample

Blood sample will be collected for performed for HIV serology, B and C hepatitis.

DIAGNOSTIC_TEST

questionnaire on sun exposure

Questionnaire on sun exposure will be completed by patients.

DIAGNOSTIC_TEST

examination of the scalp

A complete examination of the scalp will be completed by dermatologist.

DIAGNOSTIC_TEST

Norwood scale

Norwood scale measure the evolution of baldness. It will be completed by dermatologist.

DIAGNOSTIC_TEST

questionnaire of clinicals signs

Questionnaire of clinicals signs will be completed by dermatologist and patient.

DIAGNOSTIC_TEST

scinexa score

It's a assessment score of skin aging. It will be completed by dermatologist.

DIAGNOSTIC_TEST

questionnaire of the history of the hair loss

Questionnaire of the history of the hair loss will be completed by dermatologist and patient.

Sponsors & Collaborators

  • Pierre Fabre Dermo Cosmetique

    collaborator INDUSTRY
  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • JEAN LUC PERROT, MD · CHU SAINT-ETIENNE

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-14
Primary Completion
2019-09-20
Completion
2019-09-20

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03603587 on ClinicalTrials.gov